Vaccinex (VCNX) SEC Filings & 10K Form $0.70 +0.02 (+2.94%) As of 09/19/2025 09:32 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Vaccinex SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView04/15/20254:12 PMVaccinex (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 04/01/20256:01 AMVaccinex (Filer)Form NT 10-K03/27/20257:24 AMVaccinex (Filer)Form 15-12G03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/20257:38 AMVaccinex (Filer)Form POS AM03/25/20257:40 AMVaccinex (Filer)Form POS AM03/25/20257:41 AMVaccinex (Filer)Form POS AM03/25/20257:43 AMVaccinex (Filer)Form POS AM03/25/20257:45 AMVaccinex (Filer)Form POS AM03/25/20257:46 AMVaccinex (Filer)Form POS AM03/25/20257:48 AMVaccinex (Filer)Form POS AM03/25/20257:50 AMVaccinex (Filer)Form POS AM03/25/20257:51 AMVaccinex (Filer)Form POS AM03/25/20257:24 AMVaccinex (Filer)Form S-8 POS03/25/20257:26 AMVaccinex (Filer)Form S-8 POS03/25/20257:28 AMVaccinex (Filer)Form POS AM03/25/20257:30 AMVaccinex (Filer)Form POS AM03/25/20257:31 AMVaccinex (Filer)Form POS AM03/25/20257:34 AMVaccinex (Filer)Form POS AM03/25/20257:35 AMVaccinex (Filer)Form POS AM03/25/20257:36 AMVaccinex (Filer)Form POS AM03/19/20253:15 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/07/20254:21 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20253:43 PMARMISTICE CAPITAL, LLC (Filed by)Vaccinex (Subject)Form SCHEDULE 13G/A12/17/20248:32 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/18/20243:15 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A10/25/20243:11 PMVaccinex (Filer)Form 424B310/24/202411:15 PMVaccinex (Filer)Form EFFECT10/16/20243:44 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 10/09/20243:37 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:11 PMVaccinex (Filer)Form DNotice of Exempt Offering of Securities 09/20/20244:15 PMFCMI Parent Co. (Filed by)Vaccinex (Subject)Form SC 13D/A09/20/20243:57 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A09/19/20247:30 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Capstone Therapeutics SEC Filings Sonoma Pharmaceuticals SEC Filings Nuvilex SEC Filings Cardio Diagnostics SEC Filings CERo Therapeutics SEC Filings Sunshine Biopharma SEC Filings AIM ImmunoTech SEC Filings Polyrizon SEC Filings Acurx Pharmaceuticals SEC Filings Entero Therapeutics SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VCNX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.